CUTERA INC (CUTR)
US2321091082 - Common Stock
Taking everything into account, CUTR scores 2 out of 10 in our fundamental rating. CUTR was compared to 193 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CUTR have multiple concerns. CUTR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CUTR has reported negative net income.
In the past year CUTR has reported a negative cash flow from operations.
CUTR had negative earnings in 4 of the past 5 years.
CUTR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
CUTR has a Return On Assets of -41.15%. This is in the lower half of the industry: CUTR underperforms 61.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.15% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-19.17%
ROA(5y)-17.27%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CUTR has a Gross Margin of 30.95%. This is in the lower half of the industry: CUTR underperforms 73.58% of its industry peers.
In the last couple of years the Gross Margin of CUTR has declined.
CUTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.95% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.85%
GM growth 5Y-10.46%
2. Health
2.1 Basic Checks
CUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CUTR has more shares outstanding
CUTR has more shares outstanding than it did 5 years ago.
CUTR has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -1.16, we must say that CUTR is in the distress zone and has some risk of bankruptcy.
CUTR has a Altman-Z score (-1.16) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.16 |
ROIC/WACCN/A
WACC5.16%
2.3 Liquidity
A Current Ratio of 3.17 indicates that CUTR has no problem at all paying its short term obligations.
CUTR has a Current ratio (3.17) which is in line with its industry peers.
CUTR has a Quick Ratio of 2.44. This indicates that CUTR is financially healthy and has no problem in meeting its short term obligations.
CUTR has a Quick ratio of 2.44. This is comparable to the rest of the industry: CUTR outperforms 50.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.17 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
CUTR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -394.44%.
The Revenue for CUTR has decreased by -15.91% in the past year. This is quite bad
The Revenue has been growing slightly by 5.47% on average over the past years.
EPS 1Y (TTM)-394.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1250%
Revenue 1Y (TTM)-15.91%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Revenue growth Q2Q-26.44%
3.2 Future
The Earnings Per Share is expected to grow by 11.40% on average over the next years. This is quite good.
CUTR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.61% yearly.
EPS Next Y11.14%
EPS Next 2Y15.22%
EPS Next 3Y13.78%
EPS Next 5Y11.4%
Revenue Next Year-22.56%
Revenue Next 2Y-8.29%
Revenue Next 3Y-2.56%
Revenue Next 5Y4.61%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CUTR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CUTR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CUTR's earnings are expected to grow with 13.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.22%
EPS Next 3Y13.78%
5. Dividend
5.1 Amount
CUTR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CUTERA INC
NASDAQ:CUTR (5/16/2024, 7:00:00 PM)
After market: 2.32 -0.03 (-1.28%)2.35
-0.24 (-9.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap46.91M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.15% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 30.95% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.17 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-394.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.91%
Revenue growth 3Y12.87%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y